Prolonged-release budesonide for mild-to-moderate ulcerative colitis

Cortiment is a new multimatrix (MMX) prolongedrelease formulation of budesonide for the treatment of mild-to-moderate active ulcerative colitis, which releases budesonide at a controlled rate throughout the colon. Here, Steve Chaplin outlines the clinical trial data for its efficacy and Jonathan Digby-Bell discusses its place in therapy.

Prolonged-release budesonide for mild-to-moderate ulcerative colitis

Add yours ↓
Web design and marketing agency Leamington Spa